Cellectar Biosciences Inc CLRBNasdaq
2.6USDClose on 08/10
At a glance
Cellectar Biosciences Inc sits in the ‘Resting’ stage of its cycle. It has moved -97.1% since its first surge signal on 2024-07-22, when the past-year gain stood at +52.5%.
- Since surge signal
- -97.1%
- First surge signal
- 2024-07-22
- Price at signal
- 90.6
- Past-year gain (at signal)
- +52.5%
- Sector
- Health Care
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.